The Sunshine Law (officially known as the National Physician Payment Transparency Program) creates greater transparency around the financial relationships of manufacturers, physicians, and teaching hospitals.
The Sunshine Law requires that the following information is reported annually to CMS:
- Applicable manufacturers of covered drugs, devices, biologicals, and medical supplies to report payments or other transfers of value they make to physicians and teaching hospitals to CMS.
- Applicable manufacturers and applicable group purchasing organizations (GPOs) to report to CMS certain ownership or investment interests held by physicians or their immediate family members.
- Applicable GPOs to report to CMS payments or other transfers of value made to physician owners or investors if they held ownership or an investment interest at any point during the reporting year.
CMS will collect this data, aggregate it, and publish it on a public website. Please click here for more information: SUNSHINE
DME INFO 